BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12417717)

  • 1. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
    Huot TJ; Rowe J; Harland M; Drayton S; Brookes S; Gooptu C; Purkis P; Fried M; Bataille V; Hara E; Newton-Bishop J; Peters G
    Mol Cell Biol; 2002 Dec; 22(23):8135-43. PubMed ID: 12417717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
    Brookes S; Rowe J; Ruas M; Llanos S; Clark PA; Lomax M; James MC; Vatcheva R; Bates S; Vousden KH; Parry D; Gruis N; Smit N; Bergman W; Peters G
    EMBO J; 2002 Jun; 21(12):2936-45. PubMed ID: 12065407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic ras and p53 cooperate to induce cellular senescence.
    Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
    Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
    Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
    Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.
    Rizos H; Darmanian AP; Holland EA; Mann GJ; Kefford RF
    J Biol Chem; 2001 Nov; 276(44):41424-34. PubMed ID: 11518711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
    Sebastian T; Johnson PF
    Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
    Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
    Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
    Ohtani N; Zebedee Z; Huot TJ; Stinson JA; Sugimoto M; Ohashi Y; Sharrocks AD; Peters G; Hara E
    Nature; 2001 Feb; 409(6823):1067-70. PubMed ID: 11234019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
    Groth A; Weber JD; Willumsen BM; Sherr CJ; Roussel MF
    J Biol Chem; 2000 Sep; 275(35):27473-80. PubMed ID: 10842176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
    Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-SĂ©guin N
    Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
    Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
    Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1.
    Itahana K; Zou Y; Itahana Y; Martinez JL; Beausejour C; Jacobs JJ; Van Lohuizen M; Band V; Campisi J; Dimri GP
    Mol Cell Biol; 2003 Jan; 23(1):389-401. PubMed ID: 12482990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
    Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
    Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
    Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; CatricalĂ  C; O'Toole KM
    Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.